Imaging Collaterals in Acute Stroke (iCAS)
Trial ID or NCT#
Status
Purpose
Stroke is caused by a sudden blockage of a blood vessel that delivers blood to the brain. Unblocking the blood vessel with a blood clot removal device restores blood flow and if done quickly may prevent the disability that can be caused by a stroke. However, not all stroke patients benefit from having their blood vessel unblocked. The aim of this study is to determine if special brain imaging, called MRI, can be used to identify which stroke patients are most likely to benefit from attempts to unblock their blood vessel with a special blood clot removal device. In particular, we will assess in this trial whether a noncontrast MR imaging sequence, arterial spin labeling (ASL), can demonstrate the presence of collateral blood flow (compared with a gold standard of the angiogram) and whether it is useful to predict who will benefit from treatment.
Official Title
Imaging Collaterals in Acute Stroke
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
Gregory Zaharchuk, MD
650-723-4448
View on ClinicalTrials.gov